Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7.23M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
56.8M
-
Shares change
-
-3.12M
-
Total reported value, excl. options
-
$139M
-
Value change
-
-$10.7M
-
Put/Call ratio
-
0.8
-
Number of buys
-
56
-
Number of sells
-
-75
-
Price
-
$2.45
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2023
153 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q2 2023.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.8M shares
.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (7.17M shares), Avidity Partners Management LP (6.08M shares), ORBIMED ADVISORS LLC (5.46M shares), BlackRock Inc. (5.09M shares), Prosight Management, LP (4.65M shares), MILLENNIUM MANAGEMENT LLC (3.74M shares), VANGUARD GROUP INC (3.03M shares), SPHERA FUNDS MANAGEMENT LTD. (1.99M shares), Granahan Investment Management, LLC (1.9M shares), and FRANKLIN RESOURCES INC (1.39M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.